Resveratrol

angiotensin converting enzyme 2 ; Homo sapiens







12 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 32345140 Stilbene-based natural compounds as promising drug candidates against COVID-19. 2021 Jun 3
2 33459225 Natural Agents Modulating ACE-2: A Review of Compounds with Potential against SARS-CoV-2 Infections. 2021 1
3 34064568 Role of Resveratrol in Prevention and Control of Cardiovascular Disorders and Cardiovascular Complications Related to COVID-19 Disease: Mode of Action and Approaches Explored to Increase Its Bioavailability. 2021 May 11 1
4 34160563 ACE2 Expression Is Upregulated in Inflammatory Corneal Epithelial Cells and Attenuated by Resveratrol. 2021 Jun 1 1
5 34356672 Interference of Polydatin/Resveratrol in the ACE2:Spike Recognition during COVID-19 Infection. A Focus on Their Potential Mechanism of Action through Computational and Biochemical Assays. 2021 Jul 16 1
6 34402717 Resveratrol supplementation reduces ACE2 expression in human adipose tissue. 2021 Dec 4
7 34824739 Molecular Docking and ADMET Prediction of Natural Compounds towards SARS Spike Glycoprotein-Human Angiotensin-Converting Enzyme 2 and SARS-CoV-2 Main Protease. 2021 Summer 1
8 32310688 Biological plausibility for interactions between dietary fat, resveratrol, ACE2, and SARS-CoV illness severity. 2020 May 1 1
9 32656311 Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor. 2020 Jun 2
10 32685191 The angiotensin-converting enzyme 2 (ACE2) receptor in the prevention and treatment of COVID-19 are distinctly different paradigms. 2020 1
11 32985211 Potential therapeutic effects of Resveratrol against SARS-CoV-2. 2020 2
12 28935757 Resveratrol Inhibits Growth of Experimental Abdominal Aortic Aneurysm Associated With Upregulation of Angiotensin-Converting Enzyme 2. 2017 Nov 1